WANG Jun
Department of Coronary Heart Disease, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, ChinaLI Xing
Department of Coronary Heart Disease, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, ChinaJIA Lu
Department of Coronary Heart Disease, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, ChinaLI Xiaomei
Department of Coronary Heart Disease, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, ChinaLIU Fen
Department of Coronary Heart Disease, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, ChinaSHAN Chunfang
Department of Coronary Heart Disease, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, ChinaJIN Siyu
Department of Coronary Heart Disease, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, ChinaYANG Yining
Department of Coronary Heart Disease, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China(Department of Coronary Heart Disease, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China)
R541.4
WANG Jun, LI Xing, JIA Lu, LI Xiaomei, LIU Fen, SHAN Chunfang, JIN Siyu, YANG Yining. Lipoprotein(a) level is independently correlated with vulnerable plaques in patients with coronary heart disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2019,27(4):293-300.
Copy